Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Group enriched"	"Detected in some"	13284	"Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Approved	Cytosol		NA	NA		1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.8	104.7	31.5	101.2	48.3	55.1	100.7	84.1	87.6	85.8	107.3	74.0	107.1	94.7	137.9	84.8	47.1	106.1	63.2	183.3	63.0	41.6	83.1	77.5	84.0	163.3	75.5	112.6	83.2	75.5	64.7	96.3	64.7	141.5	63.1	44.7	66.6	62.5	90.9	198.0	68.4	93.0	78.4	54.0	88.3	102.2	50.6	211.6	106.8	79.1	63.1	44.4	52.4	221.3	78.4	41.1	94.1	76.4	75.0	126.7	50.6	69.1	90.9	123.6	84.3	86.6	235.7	109.4	100.0	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	1628.0	0.0	0.0	0.0	0.0	0.0	1088.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1710.3	0.0	0.0	0.0	0.0	1077.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1138.4	0.0	0.0	0.0
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 1558.3"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA004177	Uncertain		Approved	Cytosol		NA	NA		1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.8	8.9	1.9	6.2	1.5	5.2	1.5	4.1	7.0	5.5	21.8	3.6	5.1	24.7	6.0	6.8	1.8	6.4	14.1	11.1	3.8	4.4	8.0	6.0	8.3	6.0	11.6	10.6	2.3	5.1	0.5	10.8	12.4	4.5	7.8	4.0	1.2	7.2	13.5	3.9	5.0	8.1	2.1	1.7	5.6	7.7	4.0	22.7	15.3	0.7	6.2	5.1	1.0	1.7	1.5	0.6	5.2	4.0	1.7	8.1	2.5	3.7	5.4	7.4	5.5	8.1	7.7	11.5	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5											11.9	25.9	269.9	530.0	703.6	362.0	0.0	315.9	36.1	40.9	40.1	111.9	0.0	94.5	100.6	190.1	242.7	1558.3	46.7	66.6	0.0	38.0	448.8	200.0	94.7	0.0	692.8	311.1	289.1	683.7	930.6	352.7	289.5	877.3	70.3	597.6	553.3	106.3	971.1	380.8	45.3	219.0	478.6	664.3	23.8	81.3	598.3	0.0	258.9	731.1	912.8
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 2651.5;Proximal tubular cells: 6429.5"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA002198, CAB020827"	Enhanced					NA	NA		930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.4	0.0	3.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.5	0.2	0.4	0.0	0.2	3.1	15.6	0.0	0.0	2.6	13.5	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.4	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	48.6	0.0	0.0	1.0	0.9	448.4	0.0	0.0	143.1	0.0	0.0	525.6	3.8	0.0	0.0	62.6	46.7	221.2	0.0	0.0	0.0	0.0	2651.5	0.2	3.2	0.0	50.3	57.0	0.0	0.0	0.0	0.0	6.4	2.6	0.4	297.3	28.8	0.0	6429.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.5	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.5	0.5	3.5	14.7	7.4	7.6	0.7	3.9	8.8	3.0	18.5	4.4	0.7	3.5	4.6	3.4	0.8	9.9	2.4	24.1	5.6	3.1	2.3	6.8	2.8	7.5	6.9	2.5	8.0	7.0	3.4	0.3	6.0	0.4	1.3	7.3	4.6	19.1	2.6	3.6	2.9	8.3	5.5	1.6	3.9	2.4	0.4	63.4	0.4	1.0	9.4	16.7	2.2	18.1	0.1	5.8	9.8	5.6	0.9	0.3	1.4	0.5	0.6	43.8	12.5	2.6	28.6	7.1	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4	0.0	12.0	9.3	17.7	6.6	72.2	19.0	5.1	0.0	7.9	7.0	100.1	1.2	3.3	14.2	0.8	8.4	22.7	0.0	8.9	3.9	7.1	4.4	12.7	50.8	4.4	259.0	20.7	16.5	4.7	0.8	8.6	3.7	23.6	58.7	8.7	81.4	11.6	14.0	9.6	1.6	259.1	12.9	17.6	0.4	3.2	9.5	1.3	17.0	3.3	8.0
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		12000	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	18.6	8.6	34.5	10.1	22.4	4.6	15.6	8.1	35.7	18.4	16.1	16.1	10.7	9.4	13.3	8.5	20.2	11.4	11.9	23.3	25.3	18.9	8.4	24.2	7.7	4.4	18.9	15.6	15.3	39.5	9.9	10.6	9.9	12.7	13.5	10.4	8.7	21.4	21.5	41.0	19.5	9.4	21.3	16.1	5.2	11.2	11.4	11.3	1.9	9.0	12.1	10.1	16.5	11.7	1.7	0.4	0.1	0.6	0.2	2.6	0.7	20.1	14.7	15.3	26.1	20.9	18.7	15.4	22.8	18.8	18.2	16.7	9.7	17.7	13.2	11.7	36.4	16.7	14.0	13.7	23.3	8.5	13.3	26.0	8.8	10.2	22.1	16.9	8.4	0.3	16.3	27.3	13.0	26.7	19.2	21.0	5.3	16.6	8.6	14.2	14.5	4.4	8.4	21.4	14.4	18.4	15.7	20.6	20.7	12.9	9.4	27.9	23.2	10.0	31.6	15.3	8.0	13.7	10.0	16.5	31.7	40.6	21.9	25.4	3.1	6.0	5.6	14.2	6.4	21.1	0.0	0.2	0.0	2.6	0.6	2.4	1.7	1.2	2.2	0.4	0.5	0.0	2.0	0.1	0.2	0.1	0.2	1.1	0.7	34.5	22.4	8.1	35.7	25.3	18.9	18.9	15.6	12.7	11.3	0.0	12.0	0.8	8.4	6.9	13.5	12.2	7.6	2.7	4.5	14.0	3.9	1.6	1.7	12.6	14.0	7.4	5.8	0.0	17.4	6.6	10.6	10.5	0.0	17.8	2.1	17.5	15.6	4.3	0.6	5.4	15.3	1.8	3.3	2.8	19.7	7.5	21.8	7.0	11.7	8.6	12.0	6.5	6.1	3.5	13.0	11.0	0.5	1.3	13.3	14.9
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 25.4;Early spermatids: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049774: AB_2680873, HPA061695: AB_2684588"	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.9	7.6	8.0	6.4	8.4	1.8	9.1	2.4	6.7	10.5	6.5	11.6	10.6	3.8	9.0	10.5	4.8	11.0	5.3	11.5	7.8	7.2	10.9	9.7	4.9	7.6	9.8	7.1	13.9	8.6	9.0	28.4	1.8	6.6	8.1	3.9	6.7	7.2	8.7	10.8	5.2	4.0	11.3	9.5	3.7	4.5	19.0	8.1	12.1	10.1	5.2	5.6	8.6	4.0	5.5	4.7	7.8	0.9	3.3	8.2	2.6	0.9	0.9	5.9	3.2	1.8	3.5	0.7	2.4	3.4	3.7	6.0	0.8	2.8	1.7	5.7	3.9	4.3	0.9	2.1	3.5	4.4	3.9	1.7	3.7	1.5	1.8	5.0	1.6	1.6	3.7	4.7	2.2	2.3	7.2	3.4	8.6	5.8	2.7	8.1	3.8	3.4	1.4	2.6	1.3	1.5	3.0	5.0	8.8	5.5	1.1	4.5	6.1	2.2	2.9	6.7	4.9	3.5	1.3	2.4	2.5	2.1	3.4	1.4	14.0	11.4	5.3	2.9	4.4	2.7	7.8	0.3	2.4	4.9	0.7	6.4	4.0	4.9	6.4	0.5	5.5	8.2	7.8	0.6	3.3	0.9	4.7	4.2	2.6	8.0	8.4	2.4	6.7	7.8	7.2	9.8	7.1	6.6	8.1	8.9	4.5	2.0	4.7	2.5	4.5	9.1	2.5	25.4	13.6	3.5	0.0	1.6	21.6	3.2	25.3	1.6	1.2	0.0	2.9	1.1	3.2	4.0	3.5	4.3	0.5	4.8	8.1	0.6	0.3	19.0	3.7	1.1	3.3	0.0	2.2	10.5	2.7	0.9	2.8	9.1	5.9	0.0	1.9	18.5	12.9	3.8	0.3	4.3	2.3	2.0
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119879	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7"	"Group enriched"	"Detected in all"	9	"dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3000000	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	27.5	19.6	13.8	17.0	14.8	11.3	18.6	14.3	23.0	14.9	16.5	23.4	21.7	19.4	20.1	50.9	13.9	18.2	23.5	21.4	13.5	17.6	27.9	44.2	34.0	30.2	18.1	16.1	14.6	29.4	28.8	24.7	84.1	14.9	22.3	7.2	21.9	27.5	22.1	26.3	18.3	15.4	17.2	16.6	35.8	17.4	30.7	14.6	13.9	21.9	14.9	13.5	24.0	13.4	1.4	15.6	10.8	24.7	1.1	1.8	9.8	11.4	22.4	4.4	14.5	13.9	14.0	28.9	7.2	13.3	5.5	4.5	6.6	18.7	4.1	19.2	5.6	4.7	4.9	1.4	8.3	1.3	5.3	16.7	0.0	3.8	23.7	24.2	0.5	13.7	30.1	12.0	10.3	3.6	11.2	9.7	11.2	4.1	17.3	4.1	26.5	1.9	2.7	9.2	2.8	15.7	10.0	15.2	7.0	4.4	12.0	5.1	14.7	9.4	10.5	12.9	2.8	30.0	16.4	6.2	20.4	11.0	14.7	2.6	41.4	11.5	1.2	6.5	10.7	12.8	0.1	23.8	8.4	1.5	20.0	1.8	1.3	1.2	1.6	15.6	1.4	1.4	0.9	10.8	1.1	24.7	3.8	0.8	9.8	13.8	14.8	14.3	23.0	13.5	17.6	18.1	16.1	14.9	14.6	17.9	45.3	3.9	14.4	10.0	15.6	14.3	30.6	5.3	17.0	14.0	7.9	106.8	5.0	23.0	42.5	17.4	18.6	0.0	13.8	125.7	30.3	19.9	8.1	23.1	92.2	11.1	5.8	29.4	107.0	25.5	22.2	64.5	23.6	31.5	14.3	28.7	9.4	17.5	18.0	18.2	16.5	6.5	10.3	18.4	26.8	7.3	139.0	7.7	15.5	10.8
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.1	30.7	1.9	8.6	2.7	6.8	7.2	6.6	5.5	6.8	6.4	17.0	1.6	12.7	8.3	3.5	5.0	4.8	2.0	1.9	0.7	5.5	19.2	7.9	11.6	28.5	9.3	5.3	17.6	6.1	2.7	3.4	1.5	3.4	15.8	7.2	6.2	7.8	4.1	34.9	14.6	19.9	2.1	3.8	15.9	17.5	21.4	21.1	3.8	3.3	4.2	11.6	5.6	14.5	14.4	1.5	11.8	8.7	13.9	10.1	9.7	9.6	5.8	19.7	4.8	3.2	11.3	12.4	7.8	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3	14.9	11.7	15.8	8.2	7.7	6.8	17.6	20.4	0.0	3.4	12.2	0.0	41.6	58.0	23.3	0.6	17.9	12.3	0.0	47.9	88.4	28.2	7.0	27.6	107.1	49.1	3.2	8.1	30.7	45.2	3.6	28.7	28.4	37.1	27.9	13.6	15.8	25.0	25.1	22.6	75.3	6.2	6.5	12.3	1.2	22.0	10.9	35.4	15.0	24.0	7.6
GALK2	GK2	ENSG00000156958	"Galactokinase 2"	Q01415	15	49155656-49367869	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043564, HPA048267"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043564: AB_2678557, HPA048267: AB_2680335"	"unprognostic (2.27e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.88e-5)"	"unprognostic (2.33e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.93e-1)"	12.7	24.9	10.2	9.2	15.3	6.5	12.4	15.7	15.3	14.7	16.3	15.3	25.6	21.5	16.0	9.9	11.5	13.5	9.9	14.2	11.3	10.3	32.3	28.4	12.7	8.0	16.2	9.4	11.5	18.5	19.4	34.2	10.8	15.3	11.1	17.9	13.2	12.2	16.3	12.5	11.6	17.9	11.8	13.9	12.8	13.9	9.2	14.8	14.6	16.7	10.9	11.5	10.3	11.6	9.6	10.4	24.2	11.3	12.8	23.1	8.7	6.3	7.4	3.4	4.5	8.8	13.7	10.0	6.6	8.8	6.6	7.8	9.4	6.7	2.0	5.3	6.9	8.2	9.3	13.5	9.4	9.3	11.4	4.0	11.8	7.0	7.9	9.6	8.1	3.7	7.1	17.3	7.0	17.5	7.6	13.3	4.9	11.8	11.5	7.1	6.8	5.9	6.5	1.4	19.3	7.1	7.2	4.2	30.6	12.2	6.0	4.1	2.7	7.3	15.2	12.4	7.1	7.5	7.9	7.2	6.4	4.4	26.3	6.2	9.5	32.7	3.9	10.0	31.1	8.8	24.2	10.6	18.6	12.8	11.3	13.6	9.6	13.1	12.6	10.4	6.7	10.5	10.7	5.4	12.8	10.8	9.2	23.1	8.7	10.2	15.3	15.7	15.3	11.3	10.3	16.2	9.4	15.3	14.8	3.0	9.3	11.5	12.7	4.9	12.6	1.1	30.6	30.8	9.1	5.2	35.3	12.4	24.9	15.8	5.0	7.1	15.5	23.3	11.4	23.6	8.9	10.4	2.3	24.2	17.8	14.3	8.6	22.7	14.6	3.1	10.6	11.0	13.5	13.6	22.6	10.3	11.8	17.0	10.6	37.9	24.8	0.0	7.5	19.1	5.4	5.5	21.5	10.8	15.8	9.5
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	5.0	6.7	6.1	2.5	8.4	8.5	7.1	3.7	10.7	3.9	4.5	8.3	4.7	5.6	3.9	4.5	1.5	2.7	1.1	10.4	0.7	8.4	4.5	2.3	13.4	8.4	8.2	1.3	3.0	12.3	6.6	2.5	3.1	8.3	9.5	7.4	1.9	6.2	6.3	4.4	4.8	9.5	2.1	5.8	1.2	7.4	5.6	3.0	10.8	7.0	1.4	5.4	4.7	9.4	5.1	4.6	8.4	7.3	1.4	1.8	3.3	3.3	0.0	3.5	2.0	1.2	4.1	4.0	9.9	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1	6.0	23.4	12.3	13.7	19.3	40.6	20.7	15.3	6.7	10.3	15.7	45.2	59.8	24.9	16.7	6.9	12.0	18.0	0.0	6.5	29.6	13.1	4.5	19.7	52.9	21.0	44.5	15.6	20.3	11.9	31.3	17.0	13.3	20.3	14.4	15.1	18.9	8.5	21.8	13.1	29.4	37.0	6.5	10.1	4.2	4.7	17.7	49.4	23.3	19.8	7.8
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	13.3	14.0	12.5	17.3	20.7	17.6	14.4	16.6	14.2	15.8	14.3	25.6	15.4	11.7	17.9	26.0	20.7	12.9	13.0	12.4	13.4	10.4	13.5	18.0	30.5	13.8	25.0	13.7	18.8	13.1	17.4	20.5	10.8	19.8	13.1	17.8	18.3	20.4	13.7	23.9	13.9	15.4	15.9	25.1	15.5	13.1	24.5	22.6	17.4	16.8	12.3	18.3	16.2	16.3	17.6	12.2	9.3	10.1	4.0	7.4	4.7	6.2	3.2	7.9	8.6	9.6	13.6	5.0	13.7	14.8	15.1	12.7	4.7	4.4	3.4	7.5	13.8	10.5	13.0	9.5	14.6	10.5	8.5	4.4	8.5	8.6	9.2	8.1	8.2	7.4	9.2	8.7	6.1	10.5	8.5	10.2	8.7	8.8	9.6	11.9	1.3	5.5	9.1	4.9	2.7	4.2	10.6	9.3	11.8	11.4	5.8	6.0	8.5	7.7	6.7	4.8	4.5	2.5	19.4	9.2	15.9	4.2	13.1	8.2	10.4	13.7	6.9	7.5	15.1	8.7	9.3	9.3	7.4	3.7	10.1	5.0	16.2	5.7	6.9	12.2	17.6	7.4	4.4	5.0	4.0	8.1	9.6	5.5	4.7	12.5	20.7	16.6	14.2	13.4	10.4	25.0	13.7	19.8	22.6	17.9	36.3	8.3	15.1	9.3	5.1	6.9	2.5	12.0	10.3	1.8	9.8	4.4	5.0	4.3	9.0	4.0	8.4	0.0	3.3	4.2	4.5	6.5	10.4	9.0	6.0	3.2	4.1	7.4	11.6	3.0	6.6	10.3	13.5	11.8	5.5	10.4	5.0	16.5	6.0	6.3	6.5	12.9	5.2	14.2	14.4	4.5	2.4	5.0	7.5	21.3
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101397803-101407925	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 85.3;Melanocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		910000			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	21.1	22.2	5.2	10.0	6.3	15.6	19.2	6.2	5.7	10.8	12.7	7.3	23.2	14.8	11.7	14.1	9.4	11.5	9.1	10.5	5.2	6.3	28.7	18.9	18.7	12.0	9.4	3.2	9.7	8.3	9.8	10.5	17.9	8.6	8.3	11.2	9.4	9.5	47.7	5.9	8.9	21.3	10.8	11.9	20.8	8.5	4.9	5.8	10.2	8.3	13.4	11.2	12.2	8.9	5.4	15.9	12.8	20.9	3.0	6.1	10.1	7.2	28.4	8.2	8.4	19.0	7.4	3.7	8.3	13.0	15.9	45.3	15.4	11.2	8.0	17.7	8.5	37.5	17.3	16.1	9.0	13.8	4.9	12.0	4.4	23.6	18.1	4.9	6.1	81.0	6.5	2.9	18.3	5.3	4.4	12.8	4.9	6.8	17.7	15.1	12.9	6.1	12.7	12.0	17.3	11.5	4.4	10.1	19.5	23.2	14.7	3.0	5.1	19.3	8.2	7.7	14.2	3.8	12.6	7.3	5.5	6.6	13.1	6.7	5.4	6.2	6.1	9.5	10.2	6.1	9.5	20.8	6.2	4.6	20.9	6.1	5.4	3.7	5.7	15.9	4.9	3.8	4.7	12.8	3.0	20.8	6.7	4.3	10.1	5.2	6.3	6.2	5.7	5.2	6.3	9.4	3.2	8.6	5.8	14.9	12.2	18.9	23.0	26.9	3.8	6.7	0.0	22.7	17.0	10.4	5.9	35.6	14.9	19.5	2.6	19.0	23.9	0.0	16.1	22.7	43.3	16.3	30.1	5.7	85.3	7.9	32.5	5.5	21.1	0.8	10.3	80.3	84.4	37.9	6.8	17.7	15.1	17.5	17.0	7.9	4.6	6.5	71.0	6.0	5.5	20.7	63.2	10.7	12.3	13.2
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"	NA	NA					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.4	7.4	9.1	3.4	4.1	8.7	5.2	4.9	1.6	6.9	0.8	3.7	3.6	3.9	1.3	1.9	4.0	4.1	2.2	3.3	2.5	6.2	3.9	18.3	0.9	4.0	10.8	2.5	4.9	3.0	12.3	4.6	3.8	1.5	4.8	4.8	3.5	2.1	2.5	1.1	0.9	1.2	2.2	3.7	3.4	10.5	1.4	4.3	3.9	3.4	4.8	4.0	4.7	7.5	2.2	3.6	4.4	5.3	2.5	2.2	4.6	1.3	1.3	8.1	1.1	11.0	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4	3.0	3.2	0.8	2.5	1.5	4.8	1.7	2.5	24.1	7.9	3.5	11.8	2.9	3.3	3.1	21.1	2.5	2.1	0.0	1.6	1.5	4.4	2.7	0.0	1.0	11.7	3.2	4.7	9.8	6.1	17.2	10.0	4.5	8.5	1.0	2.8	3.5	1.7	2.3	6.0	15.3	9.5	6.5	1.2	80.3	5.4	1.5	1.1	2.1	1.7	1.6
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 359.6;Proximal tubular cells: 948.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;Hep G2: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		NA	NA		320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	14.0	10.7	1.7	6.4	1.2	0.3	1.4	1.0	0.6	1.3	0.8	5.1	3.1	2.1	3.4	0.0	1.5	6.2	5.5	1.8	0.4	5.0	10.1	18.6	2.8	27.1	0.6	2.5	2.2	0.1	0.8	1.6	0.1	0.7	1.2	3.0	3.3	3.6	0.1	9.1	3.0	2.0	2.3	12.7	4.2	10.7	0.8	11.8	1.6	1.7	6.0	9.4	2.1	3.6	4.0	0.6	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.9	3.6	1.8	6.1	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6	3.0	5.9	9.6	2.3	3.2	3.6	1.9	15.3	0.0	1.2	38.4	2.0	2.6	109.5	3.1	0.8	5.8	12.3	0.0	2.6	3.6	1.9	0.9	4.6	359.6	7.5	6.4	5.8	6.7	13.2	3.6	1.7	5.8	8.5	1.0	5.9	8.5	2.7	1.7	1.4	948.1	5.2	0.0	4.5	0.9	6.8	5.9	7.9	4.6	14.3	1.0
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"breast: 217.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;MCF7: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	217.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 368.5;Late spermatids: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.8	67.3	4.5	0.1	4.5	9.5	58.8	29.8	10.7	30.2	36.4	70.9	50.9	5.7	23.8	21.4	28.0	38.9	23.0	46.5	31.8	16.1	17.7	20.7	32.4	3.8	10.7	8.3	34.8	4.4	10.5	31.7	15.8	45.8	58.1	24.3	5.7	0.2	33.4	37.4	28.3	9.0	7.4	21.0	23.6	22.2	7.5	23.1	32.7	18.8	12.4	10.7	21.1	18.0	26.4	56.5	14.8	13.1	69.9	20.6	11.1	62.1	32.4	32.7	29.5	20.5	52.9	16.0	12.6	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8	3.0	6.5	16.7	44.9	25.4	38.3	113.1	10.2	21.4	27.3	61.1	51.1	2.1	36.5	101.2	368.5	28.8	46.6	0.0	9.2	171.9	17.4	35.9	56.4	0.8	28.5	39.7	35.7	14.1	12.6	396.4	6.9	16.2	18.6	21.6	19.5	104.9	80.1	28.1	6.3	2.1	105.7	12.9	30.8	39.9	3.2	19.7	22.2	27.3	24.5	48.7
RPL36A	"L36A, RPL44"	ENSG00000241343	"Ribosomal protein L36a"	P83881	X	101390824-101396154	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Undifferentiated cells: 3155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA063979, HPA077586"	Uncertain		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA063979: AB_2685164, HPA077586: AB_2686846"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (8.81e-11)"	"unprognostic (1.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	62.9	40.7	50.7	81.5	53.8	139.8	136.1	27.7	46.8	65.3	71.0	25.1	53.4	45.6	67.5	71.4	77.1	59.0	60.6	54.9	43.1	31.1	47.3	60.1	43.4	190.1	42.1	50.6	165.3	171.4	15.0	35.1	44.7	41.8	55.9	68.3	26.1	158.1	71.5	125.7	96.5	54.1	65.5	44.6	67.9	54.6	26.3	32.6	60.8	69.3	118.6	104.0	71.9	74.0	162.9	113.2	13.7	74.2	86.7	175.5	199.2	121.6	65.9	101.2	49.8	124.8	224.0	64.8	93.8	102.9	123.1	188.1	78.0	62.6	235.8	93.9	77.8	75.9	82.2	151.3	131.4	128.3	83.0	166.0	109.0	116.2	71.9	179.5	198.3	105.1	212.5	248.1	99.7	184.9	165.2	113.8	103.1	131.7	126.8	99.1	175.3	91.8	236.6	134.6	252.8	134.0	86.2	221.6	184.8	112.5	50.8	68.0	135.7	87.6	98.4	167.8	84.2	47.5	224.4	105.0	36.6	89.6	101.0	95.0	108.0	154.1	186.4	45.0	295.6	39.0	12.5	74.2	13.7	86.6	73.6	140.3	162.9	162.3	120.6	111.4	134.0	175.5	156.7	7.2	86.7	70.4	113.2	84.9	199.2	50.7	53.8	27.7	46.8	43.1	31.1	42.1	50.6	41.8	32.6	408.0	871.7	1431.2	350.0	815.0	25.3	12.6	713.4	501.9	1443.4	165.7	13.7	675.4	368.1	934.6	6.2	708.2	731.9	397.1	2614.9	904.3	568.3	225.8	1204.1	656.9	533.8	14.3	1058.9	1162.0	2037.4	20.4	977.8	917.6	497.7	1450.9	2170.9	77.3	2295.7	1329.1	393.5	579.9	33.5	232.8	598.3	23.3	110.3	980.8	628.4	1100.0	3155.0	282.8
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	79.9	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	29.8	0.0
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA		12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.5	14.5	13.9	9.3	47.4	61.5	58.3	35.6	29.1	19.2	22.9	37.1	23.4	28.9	10.7	38.2	17.5	12.1	16.8	22.3	31.2	19.3	7.1	18.3	10.3	25.3	22.7	16.1	16.1	40.3	40.9	18.0	18.6	25.9	26.6	9.8	9.1	11.7	80.1	10.8	21.8	15.2	33.3	45.0	10.2	17.9	27.6	16.6	34.0	16.0	7.3	6.0	28.4	36.6	13.5	44.1	10.4	11.5	36.3	20.1	31.7	29.9	18.7	21.0	9.4	36.6	24.1	25.3	61.3	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5	26.8	52.5	51.7	74.0	67.3	48.5	238.8	89.2	73.6	69.4	45.4	60.9	359.1	205.6	116.3	61.0	61.3	412.6	0.0	90.6	369.3	148.4	77.6	65.8	448.9	107.3	82.6	42.9	66.3	100.6	64.7	73.4	90.8	91.1	173.1	112.3	37.4	81.0	167.8	72.9	209.2	49.4	71.1	124.3	71.2	57.5	50.6	395.3	112.8	144.5	90.3
